Filing Details
- Accession Number:
- 0000899243-20-035007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-23 17:24:07
- Reporting Period:
- 2020-12-21
- Accepted Time:
- 2020-12-23 17:24:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1815185 | W. Jason Myers | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Yes | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-21 | 3,232 | $47.10 | 806,482 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-21 | 3,935 | $47.81 | 802,547 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-21 | 19,297 | $49.24 | 783,250 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-21 | 73,310 | $49.95 | 709,940 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-21 | 200 | $50.55 | 709,740 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-22 | 4,700 | $51.73 | 705,040 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-22 | 70,942 | $52.84 | 634,098 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-22 | 42,338 | $53.43 | 591,760 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-22 | 7,011 | $54.27 | 584,749 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on October 1, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $46.50 to $47.49 per share.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents a weighted average sale price. Actual sale prices ranged from $47.52 to $48.44 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $48.54 to $49.53 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $49.54 to $50.53 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $50.54 to $50.55 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $51.08 to $52.07 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $52.08 to $53.07 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $53.08 to $54.07 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $54.08 to $54.57 per share.
Billionaire Hedge Funds
